What is the composition of the $43.9 million adjusted EBITDA (e.g., operating margin, depreciation, amortization, and non‑recurring items)? | ADUS (Aug 06, 2025) | Candlesense
ADUS

What is the composition of the $43.9 million adjusted EBITDA (e.g., operating margin, depreciation, amortization, and non‑recurring items)?

Answer – The news release does not break out the $43.9 million Adjusted EBITDA

The Business Wire announcement you provided contains only a headline‑level summary of Addus HomeCare’s second‑quarter 2025 performance. It tells us that Adjusted EBITDA grew 24.5 % year‑over‑year to $43.9 million, but it does not provide a line‑item composition (i.e., what portion is operating profit, depreciation & amortization, or any non‑recurring items that were added back or excluded).

What we can infer from the limited information

Metric (Q2 2025) Value (from the summary)
Adjusted EBITDA $43.9 million (up 24.5 % YoY)
Net Service Revenues $349.4 million (up 21.8 %)
Net Income $22.1 million (≈ $1.20 per diluted share)
Adjusted Net Income per diluted share $1.49 (up 10.4 % YoY)

What's missing (the “composition” you are asking about)

  • Operating margin – Not disclosed.
  • Depreciation & amortization – No figures provided.
  • Non‑recurring/adjusted items – No detail about what was added back (e.g., acquisition‑related integration costs, one‑time gains or losses, stock‑based compensation adjustments, etc.).

Where to find the detailed breakdown

The detailed composition of Adjusted EBITDA is typically disclosed in one of the following places:

  1. Full Earnings Release – The full press‑release (not just the headline excerpt) normally contains a table showing Adjusted EBITDA with its underlying components (e.g., operating profit, depreciation, amortization, non‑recurring items). You can usually find the full release on the company website under the “Investors”‑> “Press Releases” section.
  2. Form 10‑Q (Quarterly Report) – The quarterly filing with the SEC (Form 10‑Q) includes the Management’s Discussion and Analysis (MD&A) and a reconciliation of GAAP operating profit to Adjusted EBITDA. This is the most reliable source for the exact breakdown.
  3. Earnings Call Transcript – Often the CFO or CEO will discuss which items were excluded (e.g., acquisition-related costs, one‑time legal settlements, etc.) and give a percentage or dollar amount for each component.
  4. Investor Presentation Slides – Companies often provide a slide with an “Adjusted EBITDA Reconciliation” that lists the specific adjustments.

How to proceed

  • Visit Addus HomeCare’s investor website: https://ir.addus.com/ → “Financials” → “Quarterly Results” → “Q2 2025”.
  • Locate the “Form 10‑Q” filed for the quarter ended June 30 2025; the “Non‑GAAP Financial Measures” section will contain the reconciliation.
  • Look for the earnings‑release PDF on the same page; the PDF typically includes a table titled “Adjusted EBITDA Reconciliation” or something similar.

If you need a specific line‑item breakdown for a particular analysis (e.g., valuation or margin trending), you’ll need to pull the data from those source documents. The excerpt you have shared does not contain the detail you are asking for and therefore cannot provide the composition of the $43.9 million Adjusted EBITDA.

Other Questions About This News

Are there any upcoming regulatory changes or reimbursement policy shifts that could affect future revenue or margins? How did the adjusted EBITDA margin change versus the prior quarter and year‑over‑year? How did the adjusted net income per diluted share growth (10.4%) compare to the growth of net service revenue (21.8%)? How did the reported earnings per share compare to analyst consensus estimates? How does the cash flow from operations compare to the prior quarter and to the company’s cash conversion ratio target? Did the company provide revised guidance for FY 2025, and how does it compare to prior guidance and consensus expectations? How does Addus HomeCare’s revenue growth and margin profile compare with its main competitors in the home‑care sector? How sustainable is the 21.8% revenue growth given the company’s historical growth rates and market conditions? What are the key risks highlighted by management (e.g., staffing shortages, labor costs, or reimbursement pressure) that could affect future performance? What impact will the reported results have on the stock’s technical indicators (e.g., moving averages, volume trends) and likely short‑term price movement? What is the current debt load and net leverage ratio after this quarter’s results? What is the expected impact on earnings per share in the next quarter and the full‑year outlook based on the current trajectory? What were the drivers behind the 21.8% revenue growth – new client acquisition, higher visit volume, or price increases? What is the company’s capital allocation plan—share buybacks, dividend increases, or reinvestment in growth—following this quarter’s performance? What was the YoY change in revenue and how much of it was organic versus acquisition driven?